Back
Pliant Therapeutics 10K Form
Buy
52
PLRX
Pliant Therapeutics
Last Price:
13.83
Seasonality Move:
15.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PLRX News And Ratings
See the #1 stock for the next 7 days that we like better than PLRX
PLRX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.58M |
|---|---|
| Cash Flow: | $-33.17M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.68 |
| Price / Book: | 2.56 |
Profitability
| EPS (TTM): | -3.34000 |
|---|---|
| Net Income (TTM): | $-201.68M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Pliant Therapeutics Earnings Forecast
Key Pliant Therapeutics Financial Ratios
- The Research & Development expenses have been 8,088.42% of Revenue.
- The Interest Expense is -0.79% of Operating Income.
- The Net Earning history of PLRX is -10,211.14% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
Pliant Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PLRX |
| CUSIP: | 729139 |
| Website: | pliantrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PLRX Technical Analysis vs Fundamental Analysis
Buy
52
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Buy
The current Pliant Therapeutics [PLRX] share price is $14.53. The Score for PLRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.